Skip to main content
Clinical Trials/CTRI/2016/07/007103
CTRI/2016/07/007103RecruitingPhase 4

comparative evaluation of oral voriconazole and oral ketoconazole as an adjunct to topical natamycin in severe fungal keratitis

DR R P Centre AIIMS New Delhi0 sites40 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 4
Status
Recruiting
Sponsor
Enrollment
40

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • SEVERE FUNGAL KERATITIS
  • EVIDENCE OF FUNGI IN SMEAR OR CULTURE
  • WILLING TO BE TREATED AS INPATIENT AND RETURN IN 3 DAYS TILL EPITHELIZATIO

Exclusion Criteria

  • EVIDENCE OF BACTERIA OR ACANTHAMOEBA ON STAIN
  • EVIDENCE OF HERPETIC KERATITIS
  • B/L OR PERFORATED ULCER
  • H/O PREVIOUS OCULAR SX
  • IMMMUNOCOMPROMISED

Investigators

Sponsor
DR R P Centre AIIMS New Delhi

Similar Trials